Hali­a's $30M Se­ries C; Windtree as­sess­es 's­trate­gic' op­tions; LifeArc, Gates in­vest in Africa ac­cel­er­a­tor

Plus, news about Cor­bus and Astel­las:

Halia Ther­a­peu­tics rais­es $30M Se­ries C: The com­pa­ny, which is de­vel­op­ing small mol­e­cules for in­flam­ma­to­ry dis­eases, plans to use …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER